357 related articles for article (PubMed ID: 29593283)
1. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance.
Meyer MA; Baer JM; Knolhoff BL; Nywening TM; Panni RZ; Su X; Weilbaecher KN; Hawkins WG; Ma C; Fields RC; Linehan DC; Challen GA; Faccio R; Aft RL; DeNardo DG
Nat Commun; 2018 Mar; 9(1):1250. PubMed ID: 29593283
[TBL] [Abstract][Full Text] [Related]
2. Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103
Zhou Y; Slone N; Chrisikos TT; Kyrysyuk O; Babcock RL; Medik YB; Li HS; Kleinerman ES; Watowich SS
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32273347
[TBL] [Abstract][Full Text] [Related]
3. Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow.
Schlitzer A; Sivakamasundari V; Chen J; Sumatoh HR; Schreuder J; Lum J; Malleret B; Zhang S; Larbi A; Zolezzi F; Renia L; Poidinger M; Naik S; Newell EW; Robson P; Ginhoux F
Nat Immunol; 2015 Jul; 16(7):718-28. PubMed ID: 26054720
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional and Functional Analysis of CD1c
Bourdely P; Anselmi G; Vaivode K; Ramos RN; Missolo-Koussou Y; Hidalgo S; Tosselo J; Nuñez N; Richer W; Vincent-Salomon A; Saxena A; Wood K; Lladser A; Piaggio E; Helft J; Guermonprez P
Immunity; 2020 Aug; 53(2):335-352.e8. PubMed ID: 32610077
[TBL] [Abstract][Full Text] [Related]
5. Type 1 Conventional CD103
Ng SL; Teo YJ; Setiagani YA; Karjalainen K; Ruedl C
Front Immunol; 2018; 9():3043. PubMed ID: 30622538
[TBL] [Abstract][Full Text] [Related]
6. IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.
Bajaña S; Turner S; Paul J; Ainsua-Enrich E; Kovats S
J Immunol; 2016 Feb; 196(4):1666-77. PubMed ID: 26746189
[TBL] [Abstract][Full Text] [Related]
7. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.
Grajales-Reyes GE; Iwata A; Albring J; Wu X; Tussiwand R; Kc W; Kretzer NM; Briseño CG; Durai V; Bagadia P; Haldar M; Schönheit J; Rosenbauer F; Murphy TL; Murphy KM
Nat Immunol; 2015 Jul; 16(7):708-17. PubMed ID: 26054719
[TBL] [Abstract][Full Text] [Related]
8. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
Cancel JC; Crozat K; Dalod M; Mattiuz R
Front Immunol; 2019; 10():9. PubMed ID: 30809220
[TBL] [Abstract][Full Text] [Related]
9. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB
Elizondo DM; Brandy NZD; da Silva RLL; Haddock NL; Kacsinta AD; de Moura TR; Lipscomb MW
Front Immunol; 2019; 10():173. PubMed ID: 30800127
[TBL] [Abstract][Full Text] [Related]
10. CD103
Lu L; Tanaka Y; Ishii N; Sasano T; Sugawara S
Eur J Immunol; 2017 Feb; 47(2):305-313. PubMed ID: 27861804
[TBL] [Abstract][Full Text] [Related]
11. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
12.
Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of LSD1 in MDS progenitors restores differentiation of CD141
Srivastava P; Tzetzo SL; Gomez EC; Eng KH; Jani Sait SN; Kuechle JB; Singh PK; De Jong K; Wiatrowski KR; Peresie J; Dimitroff A; Lynch ML; Wang J; Abrams SI; Griffiths EA; Nemeth MJ
Leukemia; 2020 Sep; 34(9):2460-2472. PubMed ID: 32099035
[TBL] [Abstract][Full Text] [Related]
14. TIM-3 Regulates CD103
de Mingo Pulido Á; Gardner A; Hiebler S; Soliman H; Rugo HS; Krummel MF; Coussens LM; Ruffell B
Cancer Cell; 2018 Jan; 33(1):60-74.e6. PubMed ID: 29316433
[TBL] [Abstract][Full Text] [Related]
15. Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c
Lu Y; Xu W; Gu Y; Chang X; Wei G; Rong Z; Qin L; Chen X; Zhou F
Front Immunol; 2019; 10():2829. PubMed ID: 31921114
[TBL] [Abstract][Full Text] [Related]
16. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
17. IRF8-Dependent Type I Conventional Dendritic Cells (cDC1s) Control Post-Ischemic Inflammation and Mildly Protect Against Post-Ischemic Acute Kidney Injury and Disease.
Li N; Steiger S; Fei L; Li C; Shi C; Salei N; Schraml BU; Zheng Z; Anders HJ; Lichtnekert J
Front Immunol; 2021; 12():685559. PubMed ID: 34234783
[TBL] [Abstract][Full Text] [Related]
18. Merocytic Dendritic Cells Compose a Conventional Dendritic Cell Subset with Low Metabolic Activity.
Audiger C; Fois A; Thomas AL; Janssen E; Pelletier M; Lesage S
J Immunol; 2020 Jul; 205(1):121-132. PubMed ID: 32461238
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 from CD103
Mittal D; Vijayan D; Putz EM; Aguilera AR; Markey KA; Straube J; Kazakoff S; Nutt SL; Takeda K; Hill GR; Waddell N; Smyth MJ
Cancer Immunol Res; 2017 Dec; 5(12):1098-1108. PubMed ID: 29070650
[TBL] [Abstract][Full Text] [Related]
20. CX3CR1+ c-kit+ bone marrow cells give rise to CD103+ and CD103- dendritic cells with distinct functional properties.
del Rio ML; Rodriguez-Barbosa JI; Bölter J; Ballmaier M; Dittrich-Breiholz O; Kracht M; Jung S; Förster R
J Immunol; 2008 Nov; 181(9):6178-88. PubMed ID: 18941208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
